Replies to post #242313 on Biotech Values

[DewDiligence]

PFE invests_$120M_in Kalamazoo plant_to_increase Paxlovid production_capacity:

https://finance.yahoo.com/news/pfizer-invest-120-million-produce-150000679.html

PFE’s guidance for 2022 Paxlovid sales remains $22B.

p.s. PFE’s Kalamazoo plant was once the main facility for the Upjohn Company.

[DewDiligence]

PFE 2Q22 results—2022 guidance for Comirnaty and Paxlovid remain $32B and $22B, respectively:

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-second-quarter-2022-results

2022 non-GAAP EPS guidance is now $6.30-6.45 (from the prior range of $6.25-6.45), despite an increased headwind of $0.24/sh from currency exchange rates (i.e. the strong US dollar).


CC slides:
https://s28.q4cdn.com/781576035/files/doc_financials/2022/q2/Q2-2022-Earnings-Charts-FINAL.pdf

Transcript of CC prepared remarks:
https://s28.q4cdn.com/781576035/files/doc_financials/2022/q2/Q2-2022-Earnings-Conference-Call-Prepared-Remarks-FINAL.pdf